RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia review published! htt…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia review published! htt…
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia review published! https://t.co/TfesuIh7P5
RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia - Mühlbauer, V - 2021 | Cochrane Library https://t.co/KYTvk8HEOR
¿Los medicamentos #antipsicóticos reducen el comportamiento agitado y los síntomas psicóticos en personas con enfermedad de #Alzheimer y #demencia vascular? https://t.co/VFJIMpelDD La nueva RS de @CochraneDCIG analiza la evidencia de 24 estudios https://t.
RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…
RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…
RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…
RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…
RT @Saludteca: Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular https://t.co/sNR3…
RT @Saludteca: Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular https://t.co/sNR3…
RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…
Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascular #dementia? https://t.co/Llfuu3lGhs New @CochraneDCIG systematic review looks at the evidence from 24 studies.
RT @Saludteca: Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular https://t.co/sNR3…
Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular https://t.co/sNR3AK9tgI 🩺Hay alguna evidencia de que los antipsicóticos típicos podrían disminuir ligeramente la agitación y la psicosis en los paci
(Cochrane) #Demencia Alguna evidencia que antipsicóticos típicos disminuyen agitación y psicosis. Atípicos reducen levemente agitación, pero efecto sobre psicosis es insignificante. Aparente eficacia práctica podría ser curso natural favorable de síntomas
RT @CochraneUK: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascula…
RT @CochraneUK: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascula…
RT @CochraneUK: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascula…
Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular - Mühlbauer, V - 2021 | Cochrane Library https://t.co/WvNSBtZ13f
RT @NeurologyToday: Via @CochraneLibrary: Researchers assess the efficacy and safety of antipsychotics for the treatment of agitation and p…
RT @CochraneUK: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascula…
RT @NeurologyToday: Via @CochraneLibrary: Researchers assess the efficacy and safety of antipsychotics for the treatment of agitation and p…
Summarizes 24 studies with a total of 6090 people. Essential reading to understand the evidence base.
RT @NeurologyToday: Via @CochraneLibrary: Researchers assess the efficacy and safety of antipsychotics for the treatment of agitation and p…
Via @CochraneLibrary: Researchers assess the efficacy and safety of antipsychotics for the treatment of agitation and psychosis in people with #AlzheimersDisease and #VascularDementia. https://t.co/mLoiY5BwGi https://t.co/SMiSzGSxfp
(Cochrane) Papel de los Antipsicóticos en el tratamiento de la agitación en pacientes con demencia ✅Efecto muy leve ✅Altos efectos adversos ✅Muchas veces el beneficio se atribuye al curso natural del proceso. #PorMasSalud https://t.co/OL7G0nVSRK https://
¿Los medicamentos antipsicóticos reducen los comportamiento agitados y los síntomas psicóticos en personas con enfermedad de #Alzheimer y #demencia vascular? https://t.co/ICSPQBpNiU La nueva revisión sistemática de @CochraneDCIG analiza la evidencia de 24
【BPSD】Systematic Review.Alzheimer or 血管性認知症の興奮or精神病症状に対する,(定型・非定型)抗精神病薬の治療効果に関するエビデンスはごくわずか.日常診療で見られる薬剤の有効性は,プラセボ群でも見られていた. https://t.co/zXbr3Ma28A
Compensa riesgos beneficios el uso de antipsicóticos en Alzheimer o en demencia vascular? #cohrane se van a sorprender...
RT @cochrane_nz: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascu…
Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascular #dementia? https://t.co/5365NGHFsW New @CochraneDCIG systematic review looks at the evidence from 24 studies. https://t.co/BY1Kb34
RT @cochranecollab: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and va…
RT @cochranecollab: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and va…
Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascular #dementia? https://t.co/n4kwvFFi5g New @CochraneDCIG systematic review looks at the evidence from 24 studies.
RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @RMcNallyNHS: New mental health reviews from @CochraneLibrary available with a service user summary @SEdwardsNHS @PimlottBrenda Antipsy…
Thanks for the update @RMcNallyNHS. Always well worth keeping up with @CochraneLibrary and their gold standard systematic reviews. https://t.co/kD43UvhiaP
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
New mental health reviews from @CochraneLibrary available with a service user summary @SEdwardsNHS @PimlottBrenda Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia - Mühlbauer, V - 2021 | Cochrane Library
#Antipsychotics for agitation and #psychosis in people with #Alzheimer's disease and vascular dementia https://t.co/hp1nhtirzf
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…
New article: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia https://t.co/nZ7DBVZOVO #alzheimers #neurology https://t.co/gwUTDAmdBS
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…
RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…
RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…
RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…
Great joint effort on the ( limited) efficacy of antipsychotics for agitation and psychosis in dementia. @UNO_UMCG @umcg
RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…
Congratulations 🎉
It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia: https://t.co/JXyXSU2pWC @MartinDichter @SytseZuidema @DikaLuijendijk @CochraneDCIG @cochranecollab @UKKoeln @UniCologne
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! https://t.co/gDJjksapTe #Alzheimers #AlzheimersDisease #Cochrane https://t.co/q44THhtJHF